As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial
Mina C. Hosseinipour, Jeffrey N. Martin(University of California, San Francisco), Thomas Campbell(University of Colorado Anschutz Medical Campus), Rosie Mngqbisa, Deborah Langat(Kenya Medical Research Institute), Catherine Godfrey(United States Department of State), Margaret Borok(University of Zimbabwe), Jackson Orem(Uganda Cancer Institute), Wadzanai Samaneka(University of Zimbabwe), Dirk P. Dittmer(University of North Carolina at Chapel Hill), Naftali Busakhala(Moi University), John D. MacRae(Asociación Civil Impacta Salud y Educación), Susan E. Krown(Memorial Sloan Kettering Cancer Center), Brenda Hoagland(Fundação Oswaldo Cruz), Richard F. Ambinder(Johns Hopkins University), Triin Umbleja(Harvard University), Mostafa Nokta(National Institutes of Health), Noluthando Mwelase(University of the Witwatersrand), Mulinda Nyirenda(University of Malawi), Otoniel Martı́nez-Maza(University of California, Los Angeles), Minhee Kang(Cancer Research And Biostatistics), Aggrey Bukuru(Joint Clinical Research Centre), Agnes Moses
Cited by 37
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load
|Blood|2004|787
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661